16 Results for "

DPP4i

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "DPP4i" in MCE Product Catalog:

製品番号: HY-151383
CAS 番号: 2215027-46-4
Target:  

Dipeptidyl Peptidase

研究分野:  

Metabolic Disease

DPP-4-IN-1 (compound d1) is a potent DPP-4 (dipeptidyl peptidase 4) inhibitor, with an IC50of 49 nM. DPP-4-IN-1 is a structurally analogs of Alogliptin (HY-A0023A). DPP-4-IN-1 can be used for diabetes research .
製品番号: HY-146455
CAS 番号: 2402735-14-0
DPP-4-IN-3 (Compound 5a) is a potent dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC50 of 0.75 nM. DPP-4-IN-3 shows excellent antioxidant and insulinotropic activity .
製品番号: HY-155027
DPP-4-IN-8 (compound 27) is a potent and selective DPP4 (dipeptidyl peptidase 4) inhibitor, with a Ki of 0.96 μM. DPP-4-IN-8 blocks the dipeptidase activity of DPP4 in both Caco-2 and HepG-2 cells. DPP-4-IN-8 also dose-dependently suppresses the expression levels of the chemokines tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β) .
製品番号: HY-Z1764
CAS 番号: 486460-31-5
別名: Sitagliptin impurity 3
Target:  

Dipeptidyl Peptidase

研究分野:  

Metabolic Disease

DPP-4-IN-18 (Sitagliptin impurity 3) (Compound 4) impurity 3 is a potent, selective and orally active DPP-4 inhibitor with an IC50 of 27 nM. DPP-4-IN-18 can effectively prevent DPP-4 from degrading glucagon-like peptide 1 (GLP-1), thereby increasing the level of active GLP-1. DPP-4-IN-18 can be used for the research of type 2 diabetes .
製品番号: HY-103432
CAS 番号: 866396-34-1
Target:  

Drug Derivative

研究分野:  

Others

DPP4-In is an active compound.
製品番号: HY-151384
CAS 番号: 2133900-95-3
Target:  

Dipeptidyl Peptidase

研究分野:  

Metabolic Disease

DPP-4-IN-2 (compound b2) is a potent DPP-4 (dipeptidyl peptidase 4) inhibitor, with an IC50of 79 nM. DPP-4-IN-2 is a structurally analogs of Alogliptin (HY-A0023A). DPP-4-IN-2 can be used for diabetes research .
製品番号: HY-157390
CAS 番号: 2906243-39-6
Target:  

Dipeptidyl Peptidase

研究分野:  

Metabolic Disease

DPP-4-IN-9 (compound 6l) is a potent inhibitor of dipeptidyl peptidase DPP-4 (IC50: 8.22 nM). DPP-4-IN-9 has antihyperglycemic activity .
製品番号: HY-159491
DPP-4-IN-11 (compound 10) is an orally active DPP-4 inhibitor (IC50=2.75 μM) with anti-type 2 diabetes activity. DPP-4-IN-11 exerts its glucose-lowering effect by inhibiting the activities of α-glucosidase (IC50=3.02 μM) and α-amylase (IC50=3.3 μM) .
製品番号: HY-162513
CAS 番号: 1123219-12-4
Target:  

Dipeptidyl Peptidase

研究分野:  

Metabolic Disease

DPP-4-IN-10 (compound 1) is a DPP-4 inhibitor. DPP-4-IN-10 is orally active. DPP-4-IN-10 blocks the degradation of GLP-1 and GIP, which may improve glycemic control in type 2 diabetes (T2MD) .
製品番号: HY-168621
Target:  

Dipeptidyl Peptidase

研究分野:  

Metabolic Disease

DPP-4-IN-13 (compound 9i) is a competitive DPP4 inhibitor with the IC50 of 9.25 μM and can be used for study of type 2 diabetes .
製品番号: HY-169110
Target:  

Dipeptidyl Peptidase

研究分野:  

Metabolic Disease

DPP-4-IN-12 (compound 46) is a potent DPP-4 inhibitor with IC50 value of 2 nM. DPP-4-IN-12 can be used in the study of type 2 diabetes .
製品番号: HY-170657
Target:  

Dipeptidyl Peptidase

研究分野:  

Others

DPP-4-IN-14 (compound 30) is a DPP-4 inhibitor, with an IC50 of 12.82 nM .
製品番号: HY-170800
CAS 番号: 3035300-36-5
Target:  

Dipeptidyl Peptidase

研究分野:  

Others

DPP-4-IN-15 (Compound 22) is a non-competitive inhibitor of dipeptidyl peptidase-4 (DPP-4) with an IC50 of 8.24 μM .
製品番号: HY-174832
Target:  

Dipeptidyl Peptidase

研究分野:  

Metabolic Disease

DPP-4-IN-16 (Compound 92) is a potent dipeptidyl peptidase-4 (DPP-4) inhibitor (IC50=0.8 nM). DPP-4-IN-16 inhibits DPP-4-mediated degradation of incretins (e.g., GLP-1 and GIP) to promote insulin secretion and reduce blood glucose. DPP-4-IN-16 is promising for research of type 2 diabetes .
製品番号: HY-175590
Target:  

Dipeptidyl Peptidase

研究分野:  

Metabolic Disease

DPP-4-IN-17 is an orally active and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with an IC50 value of 0.12 nM. DPP-4-IN-17 increases the enzyme's Km value (75.73 μM vs. 27.18 μM of substrate alone) and reduces catalytic efficiency. DPP-4-IN-17 reduces blood glucose levels and reverses weight loss in Streptozotocin (STZ) (HY-13753)/Nicotinamide (NA) (HY-B0150)-induced diabetic rats. DPP-4-IN-17 can be used for the study of type 2 diabetes mellitus (T2DM) .
製品番号: HY-110051
CAS 番号: 866396-70-5
DPP4-In (hydrochloride) is an inhibitor of dipeptidyl peptidase 4 (DPP4) that can reduce DPP4 expression .
  • 1